Senior Scientist, Computational Imaging

Role Description

We are seeking a highly skilled Senior Scientist to lead the design, development, validation of innovative clinical workflow that can directly impact the diagnosis and treatment for heart disease. In this senior-level role, you are responsible for architecting a cutting-edge product that integrates our existing technologies while pushing the boundary of innovation in cardiac vascular imaging. You will also represent the company in strategic research collaborations with leading academic and clinical institutions, driving innovation at the intersection of AI and cardiovascular health.

Qualifications

• Ph.D. in Computer Science, Data Science, Biomedical Engineering, Biomedical Imaging, or a related technical field, with 3+ years combined postdoc and/or industry experience; OR an M.S. with 5+ years of relevant experience.
• R&D experience in medical image processing, demonstrating subject matter expertise in deep learning methods for image quality enhancements, optical flow analysis and CT harmonization.
• Proven track record of publications in top-tier medical imaging or computer vision conferences and journals (e.g., MICCAI, IEEE TMI, CVPR, Medical Image Analysis).
• Strong experience in Python, Tensorflow and pytorch.
• Prior experience with ITK, OpenCV, VTK.
• Excellent interpersonal, cross-functional, and cross-cultural collaboration skills.

Requirements

• 3+ years of industry experience in AI-based medical device development or clinical deployment.
• Experience supporting FDA regulatory submissions for ML-based software, including familiarity with De Novo, 510(k), and PCCP pathways.
• Deep domain knowledge in cardiovascular imaging and CT interpretation workflows.

Benefits

• Base Salary: $186,000 - $212,000
• Total Target Compensation (TTC): $214,000 - $245,000
• This role is eligible for a 15% target annual bonus.
• Additional total rewards include stock options, paid benefits, and employee perks.

Company Description

We’re Cleerly – a healthcare company that’s revolutionizing how heart disease is diagnosed, treated, and tracked. We were founded in 2017 by one of the world’s leading cardiologists and are a growing team of world-class engineering, operations, medical affairs, marketing, and sales leaders. We raised $223M in Series C funding in 2022 which has enabled rapid growth and continued support of our mission.

• Most of our teams work remotely and have access to our offices in Denver, Colorado, New York, New York, Dallas, Texas, and Lisbon, Portugal.
• Cleerly has created a new standard of care for heart disease through value-based, AI-driven precision diagnostic solutions.
• Our technology enables comprehensive quantification and characterization of atherosclerosis, or plaque buildup, in each of the heart arteries.
• Understanding this role's relevance and importance is critical to achieving Cleerly's quality objectives.